Trial Profile
European Intravitreal Avastin® Trial 1
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- Acronyms EURIVAT1
- 09 Nov 2016 New trial record